Beatrice Pellegrini

Dr. Beatrice Pellegrini

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Salvatore PanzaSalvatore Panza
Salvatore Panza
BPBeatrice Pellegrini
Beatrice Pellegrini
DFDorotea Fiore
Dorotea Fiore
Martine TarsitanoMartine Tarsitano
Martine Tarsitano
Antonia MancusoAntonia Mancuso
Antonia Mancuso
Donatella PaolinoDonatella Paolino
Donatella Paolino
Natural and sustainable cosmetics represent a rapidly evolving frontier in dermatological science, integrating plant-derived bioactive compounds with advanced delivery technologies and environmentally conscious formulation design. Botanical ingredients, including polyphenols, flavonoids, terpenoids, alkaloids, and polysaccharides, modulate key biological pathways involved in oxidative stress, inflammation, extracellular matrix remodeling, pigmentation, and immune responses, thereby supporting skin regeneration, protection, and homeostasis. To overcome limitations related to instability, compositional variability, and limited skin penetration, these compounds are increasingly incorporated into advanced delivery systems such as nanoemulsions, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), vesicular systems, microneedle platforms, three-dimensional matrices, and plant-derived extracellular vesicles (PDEVs). These technologies enhance cutaneous bioavailability, enable controlled release, and improve tissue targeting, linking formulation design to exposure–response relationships. In parallel, sustainability has become a critical component of product development. Circular economy strategies, including the upcycling of agro-industrial by-products, green extraction technologies, biodegradable packaging, and life cycle assessment, are reshaping cosmetic innovation. Regulatory frameworks are also evolving to address safety, efficacy, and transparency of natural claims, as well as the challenges of botanical standardization. This narrative review, conducted through a structured literature search, provides a mechanistically oriented analysis of botanical ingredients in dermatology, emphasizing molecular pathways, skin delivery science, and safety considerations. Rather than cataloguing ingredients, it proposes a translational framework linking phytochemistry, delivery science, safety-by-design principles, and sustainability to support the rational development of effective and safe dermatological formulations.

20 August 2026 in View
Verified
Journal Article
Open access
PDF file
DFDorotea Fiore
Dorotea Fiore
BPBeatrice Pellegrini
Beatrice Pellegrini
Antonia MancusoAntonia Mancuso
Antonia Mancuso
Maria Chiara CristianoMaria Chiara Cristiano
Maria Chiara Cristiano
SPSalvatore Panza
Salvatore Panza
Donatella PaolinoDonatella Paolino
Donatella Paolino
Drug delivery systems are extensively employed in dermatology to achieve high local drug concentrations and limit systemic exposure. Despite this, the stratum corneum remains a major obstacle to skin penetration, limiting the nanocarriers efficacy. In this context, plant‐derived nanovesicles (PDNVs) have recently emerged as a biological and sustainable alternative. PDNVs are lipid‐bilayer nanoparticles naturally secreted by plants that can cross biological barriers and transport a complex cargo of proteins, lipids, nucleic acids, and bioactive metabolites. This review provides a comprehensive overview of PDNVs for topical delivery focused on dermatological and cosmetic applications. We discuss definition, sources, isolation and purification strategies, characterization methodologies, storage conditions, and the influence of these parameters on vesicles yield, purity, and functional performance. Also, we provide a comparison of PDNVs with conventional vesicular nanocarriers in terms of composition, skin interaction, safety, scalability, and regulatory challenges. Finally, we summarize current preclinical and emerging evidence supporting the advantages in using PDNVs and some key points for their industrial production and clinical implementation. Taken together, all these findings suggest that PDNVs may represent a promising platform for controlled and biologically active topical delivery, alternative to conventional vesicular nanocarriers.